Therapies to Decrease Severe Respiratory Syncytial Virus Illness

• 2024

  Log in to bookmark this resource.

  Log in
• Elizabeth Scruggs-Wodkowski; Preeti Malani; Kathleen Linder
PMID: 38814625DOI: https://dx.doi.org/10.1001/jama.2024.7406

---

Access Resources

• Journal ArticleEN
• Ask aRCie About This Resource

About

This brief article discusses the use of monoclonal antibodies or protein-based vaccines to help prevent severe respiratory syncytial virus (RSV) infection in infants, children, and older adults. RSV is a virus that commonly causes respiratory infections, especially in children under 2. In the US, it leads to many hospitalizations and deaths each year, particularly among young children and older adults. Prevention is crucial as treatment is mainly supportive.

---

Tags

Focus Area: Infectious Disease

Audience: Physicians

Emergency Management Stage: Preparedness (Prevention / Protection)

Bundles: Nirsevimab Library

Keywords: Adult; Antiviral Agents; Child; Infant; Infant, Newborn; Pregnancy; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Respiratory Tract Infections; Palivizumab; Antibodies, Monoclonal, Humanized

Institutions: U.S. Department of Veterans Affairs; University of Michigan; JAMA

---

More like this

Ethical Obligations Regarding Short-Term Global Health Clinical Experiences: An American College of Physicians Position Paper 2018 · Johns Hopkins University, National Center for Ethics in Health Care, U.S. Department of Veterans Affairs, University of California –San Diego School of Medicine, University of California, San Diego, Virginia Mason Medical Center Supporting the Family After the Death of a Child or Adolescent 2023 · American Academy of Pediatrics (AAP), University of Nebraska Medical Center, U.S. Department of Veterans Affairs, University of Nebraska, Courageous Parents Network, National Association of Social Workers (NASW), Children's Mercy Kansas City Child Disaster Mental Health Interventions, Part I: Techniques, Outcomes, and Methodological Considerations 2014 · University of Oklahoma, U.S. Department of Veterans Affairs, University of Tulsa Institute of Trauma, University of Miami

---

The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

---